Compare PayPal Holdings, Inc. (PYPL) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
PayPal Holdings, Inc. vs GeneDx Holdings Corp — how do they compare? PayPal Holdings, Inc. trades at $55 (market cap $47.01B), while GeneDx Holdings Corp trades at $67.6 (market cap $2.04B). The key difference: PayPal Holdings, Inc. is far larger — about 23× GeneDx Holdings Corp's market cap, and PayPal Holdings, Inc. pays a 1.02% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold PayPal Holdings, Inc. for 106 Days and GeneDx Holdings Corp for 19 Days on average.
| PYPL | WGS | |
|---|---|---|
Market Cap | $47.01B | $2.04B |
Volume | 10,493,459 | 659,215 |
Sector | Financials | Health |
52-Week High | $75.75 | $167.51 |
52-Week Low | $39.08 | $34.51 |
Typical Hold Time | 106 Days | 19 Days |
Enterprise Value | $49.15B | $2.08B |
Dividend Yield | 1.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PayPal (PYPL) trades at $55.02, up 0.75% on the day, with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with a P/E of 10.39 and net income margin of 14.36%, while recent earnings beat expectations in two of the last three quarters. Positive sentiment is fueled by a new partnership with Meta and ongoing cost-saving initiatives under CEO Enrique Lores.
The outlook is cautiously optimistic, with a consensus price target of $56.47 offering modest upside. Key opportunities include Venmo growth and AI integration, but risks involve competitive pressures in digital payments and slowing branded checkout growth. Wall Street sentiment is mixed, with 35.71% of analysts rating it a buy.
GeneDx (WGS) trades at $68.53, down 4.18% today amid bearish technical signals despite recent positive earnings surprises. The stock shows mixed fundamentals with strong revenue growth to $454M in 2026 but negative profitability metrics including -23.4% net margin. Recent developments include new genomic testing products and hospital partnerships, while analyst consensus remains strongly bullish with a $81 price target representing 18% upside potential.
The investment case balances strong analyst support and genomic testing market growth against persistent profitability challenges and negative cash flow trends. Key catalysts include Q3 2026 earnings due soon and continued execution on operational improvements, while risks center on margin recovery timeline and competitive pressures in the rapidly evolving genomics space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About PayPal Holdings, Inc.
PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
